Auditory rehabilitation of patients with neurofibromatosis Type 2 by using cochlear implants
- 1 October 2011
- journal article
- Published by Journal of Neurosurgery Publishing Group (JNSPG) in Journal of Neurosurgery
- Vol. 115 (4) , 827-834
- https://doi.org/10.3171/2011.5.jns101929
Abstract
Object: The aim of this study was to determine whether patients with neurofibromatosis Type 2 (NF2) who have intact ipsilateral cochlear nerves can have open-set speech discrimination following cochlear implantation. Methods: Records of 7 patients with documented NF2 were reviewed to determine speech discrimination outcomes following cochlear implantation. Outcomes were measured using consonant-nucleus-consonant words and phonemes; Hearing in Noise Test sentences in quiet; and City University of New York sentences in quiet and in noise. Results: Preoperatively, none of the patients had open-set speech discrimination. Five of the 7 patients had previously undergone excision of ipsilateral vestibular schwannoma (VS). One of the patients who received a cochlear implant had received radiation therapy for ipsilateral VS, and another was undergoing observation for a small ipsilateral VS. Following cochlear implantation, 4 of 7 patients with NF2 had open-set speech discrimination following cochlear implantation during extended follow-up (15–120 months). Two of the 3 patients without open-set speech understanding had a prolonged period between ipsilateral VS resection and cochlear implantation (120 and 132 months), and had cochlear ossification at the time of implantation. The other patient without open-set speech understanding had good contralateral hearing at the time of cochlear implantation. Despite these findings, 6 of the 7 patients were daily users of their cochlear implants, and the seventh is an occasional user, indicating that all of the patients subjectively gained some benefit from their implants. Conclusions: Cochlear implantation can provide long-term auditory rehabilitation, with open-set speech discrimination for patients with NF2 who have intact ipsilateral cochlear nerves. Factors that can affect implant performance include the following: 1) a prolonged time between VS resection and implantation; and 2) cochlear ossification.Keywords
This publication has 38 references indexed in Scilit:
- Neurofibromatosis type 2 (NF2): A clinical and molecular reviewOrphanet Journal of Rare Diseases, 2009
- Auditory rehabilitation with cochlear implantation in patients with neurofibromatosis type 2Acta Oto-Laryngologica, 2009
- Hearing Rehabilitation in Neurofibromatosis Type 2 Patients: Cochlear versus Auditory Brainstem ImplantationAudiology and Neurotology, 2008
- CNAP To Predict Functional Cochlear Nerve Preservation in NF-2: Cochlear Implant or Auditory Brainstem ImplantJournal of Neurological Surgery Part B: Skull Base, 2008
- Cochlear implantation after translabyrinthine acoustic tumour removal: preliminary resultsCochlear Implants International, 2005
- Simultaneous Cochlear Implantation and Translabyrinthine Removal of Vestibular Schwannoma in an Only Hearing Ear: Report of Two Cases (Neurofibromatosis Type 2 and Unilateral Vestibular Schwannoma)Otology & Neurotology, 2005
- Auditory Brainstem Implantation in Patients with Neurofibromatosis Type 2The Laryngoscope, 2004
- Cochlear Implantation after Acoustic Tumour Resection in Neurofibromatosis Type 2: Impact of Intra- and Postoperative Neural Response Telemetry MonitoringORL, 2003
- Cochlear Implantation Concurrent With Translabyrinthine Acoustic Neuroma ResectionThe Laryngoscope, 2003
- Cochlear implantation in an intralabyrinthine acoustic neuroma patient after resection of an intracanalicular tumourThe Journal of Laryngology & Otology, 1996